Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lithium glycogen synthase kinase-3 alpha NA Successful target TTD Fragile X Syndrome[MeSHID:D005600]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 2 unknown
lithium glycogen synthase kinase-3 beta NA Clinical trial target TTD , DGIDB Fragile X Syndrome[MeSHID:D005600]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.21 phase 2 unknown
click here to return to the previous page